SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-16-000121
Filing Date
2016-06-08
Accepted
2016-06-08 09:02:13
Documents
3
Period of Report
2016-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjune2016debtrefinance.htm 8-K 36076
2 EXHIBIT 99.1 exhibit991june2016pr.htm EX-99.1 11890
3 halozymelogo.jpg GRAPHIC 701236
  Complete submission text file 0001159036-16-000121.txt   992929
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 161702764
SIC: 2836 Biological Products, (No Diagnostic Substances)